Trials / Conditions / JC Virus Infection
JC Virus Infection
5 registered clinical trials studyying JC Virus Infection — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock O NCT05101213 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic C NCT05305040 | AlloVir | Phase 2 / Phase 3 |
| Completed | Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic NCT04693637 | AlloVir | Phase 2 / Phase 3 |
| Recruiting | Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698 | M.D. Anderson Cancer Center | Phase 2 |
| Available | TETRAVI Expanded Access Program NCT07104591 | Baylor College of Medicine | — |